Rallybio forges joint venture with U.K. tech firm

A Farmington biotech startup formed by a trio of former top Alexion executives said it is working on drug discovery with an artificial intelligence company in the United Kingdom.

Rallybio, focused on rare diseases, has not yet publicly identified any drug candidates it’s pursuing, but that hasn’t stopped it from raising $37 million in venture funding.

Exscientia is at the forefront of Artificial Intelligence-driven drug discovery and design. As at 8th January 2019, Frontier IP Group Plc (LON:FIPP) have a 3.3% holding in Exscientia. Frontier IP Group, through its subsidiaries, engages in assisting universities, research institutions, and companies in the commercialization and exploitation of their intellectual property (IP) in the United Kingdom.

Read the full article

Click to view all articles for the EPIC: FIPP
Or click to view the full company profile:

Deepocean awarded contract for post-lay trenching umbilical offshore Australia

18th October 2018

DeepOcean UK, a subsidiary of DeepOcean Group Holding BV (DeepOcean), yesterday announced that the company has been awarded a contract within the Oil and Gas sector for the provision of post-lay trenching services along 65km of

Pharma sector embraces industry 4.0

16th October 2018

The medical and pharmaceutical sectors are facing disruption from companies that occupy space traditionally outside of healthcare. These are companies like Apple and Google, plus an array of startups. What does this mean for the healthcare

Preston firm raises over £1m to help transform its business

9th October 2018

A Preston manufacturing company has raised £1.34 million towards a new energy efficient factory that will transform its production capacity. Alusid, which is the first spin-out business from the University of Central Lancashire (UCLan), makes sustainable building materials

Frontier IP success in Portugal recognised by the Department for International Trade

5th October 2018

Frontier IP Chief Executive Officer Neil Crabb said: “We are honoured the DIT has recognised Frontier IP’s work in Portugal as we strive to reach our goal to be a leading IP commercialisation partner in the

University spinouts: from ideas to commercial success

3rd October 2018

Between the week just gone and the next, nearly half a million students will start university. One of them might end up starting a multi-billion-pound company. It is not a crazy claim. The UK is an

Frontier IP appoint Allenby Capital Limited nominated adviser and sole broker

27th September 2018

Frontier IP (LON:FIPP), which specialises in commercialising university intellectual property, today announced the appointment of Allenby Capital Limited as the Company’s nominated adviser and sole broker, with immediate effect.

AI’s Impact on Drug Discovery and Development

26th September 2018

Drugs cost too much, for patients, for insurers and even for pharmaceutical companies that design and sell them. A new drug can cost more than a billion dollars to bring to market, and that cost has

Alusid Raises £1.3M Funding

20th September 2018

Alusid Ltd uses a patented process to manufacture high quality building materials by recycling industrial waste ceramics and glass, which would otherwise go to landfill. The products are sold under the brand name SilicaStone. It already

Frontier IP 10 per cent stake in Amprologix Limited

20th September 2018

Neil Crabb, chief executive of Frontier IP, said: “We are delighted to work with Amprologix to commercialise these potentially life-saving antibiotics, and with a leading industrial partner in the area. It is further sign our business

Frontier IP Alusid raises £1.34 million to scale up manufacturing

18th September 2018

Frontier IP chief executive Neil Crabb said: “We’re delighted with the success of the Alusid funding round and the belief shown by investors in the potential of the Company. With consumers increasingly focused on sustainability and

Frontier IP Matthew White joining the Group as Director of Commercialisation

17th September 2018

Neil Crabb, Chief Executive of Frontier IP, said: “It is a real pleasure to welcome Matthew to the Frontier IP team. His superb range of skills and experience provide an excellent match for the work many

Artificial intelligence in drug discovery and diagnosis

13th September 2018

Machine learning is widely predicted to make drug discovery and patient diagnosis quicker, cheaper and more effective in the future, and signs of this can already be seen. Nearly 70 years ago, artificial intelligence researchers at

How could you back Britain’s brightest?

7th September 2018

In higher education, the UK is a superpower. Four of the 10 top-rated universities in the world are British. Interestingly, they’re not just centres of academic excellence. Defibrillators, LCD screens, Maglev trains, pacemakers and fibre optics are

Molecule that acts on human cells might provide hope for irresistible cold cure

3rd September 2018

Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells. Early lab-based tests with human cells have shown the molecule’s ability to completely block multiple strains of

University spin-out companies receiving large amounts of investment despite fears over Brexit

31st August 2018

According to recent reports, university spin-out companies – such as those from the University of Oxford, UK – have received large amounts of investment despite fears over Brexit. Investment in innovation, universities and spin-out companies has

Frontier IP-The Vaccine Group Ltd awarded £50,000 grant to develop anti-bacterial vaccine to combat mastitis in cows

15th August 2018

Frontier IP Group chief executive officer Neil Crabb said: “This award from a world-leading vaccinology network provides strong validation of the novel technology being developed by The Vaccine Group and its potential. We’re delighted and look

INTERVIEW: Frontier IP Group on the frontline of commercialising Portuguese technology

8th August 2018

Frontier IP Group Plc (LON:FIPP) Portfolio Manager Rui Andres talks to DirectorsTalk about the first Portuguese spin out developing novel technologies to print electronics onto paper. Rui discusses the significance of the announcement, who is behind

CEO Q&A with Neil Crabb at Frontier IP Group Plc (LON:FIPP)

7th August 2018

Frontier IP Group’s Neil Crabb discusses their partnership with the Department for International Trade, progress in Portugal, why they chose Portugal and future updates for their portfolio companies in this exclusive interview with DirectorsTalk

Be sure to check our sister interview main ratings news website